RSS   Newsletter   Contact   Advertise with us
Post Online Media

Sorrento adds Yue Alexander Wu to its board of directors

SorrentoSorrento Therapeutics, Inc., an oncology company, announced the appointment of Yue Alexander Wu to its board of .
Article continues below

READ MORE Sorrento names Douglas Ebersole to board

Dr. Wu will also serve as a member of the Compensation Committee and Audit Committee of the Board.

Dr. Wu is co-founder, President, Chief Executive Officer and Chief Scientific Officer of Crown Bioscience International, a global drug discovery and development solutions company, which he co-founded in 2006.

From 2004 to 2006, Dr. Wu was Chief Business Officer of Starvax International Inc. in Beijing, China, a biotechnology company focusing on oncology and infectious diseases.

From 2001 to 2004, Dr. Wu was a banker with Burrill & Company where he was head of Asian Activities.

Dr. Wu received his Ph.D. in Molecular Cell Biology and his MBA from University of California at Berkeley.

He earned an M.S. in Biochemistry from University of Illinois, Urbana-Champaign and his B.S. in Biochemistry from Fudan University in Shanghai, China.

Doug Ebersole has resigned as a member of the Board for personal reasons.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy